EU Pharma

Organization

Total Mentions

Documents

329

Connected Entities

Document Mentions (2)

Investment Strategy

HOUSE_OVERSIGHT_014432 - HOUSE_OVERSIGHT_014459

Dec 2, 2016Source: House Oversight

1 mention

els. The fundamental bull case for Health rests on the strong pipeline of new products for the big cap pharma universe. Our sector analysts forecast EU Pharma to deliver a 2018- 21E EPS CAGR of 11%, up from mid-single digit levels in recent years. Historically that would justify a PE re-rating and a multipl

Page: HOUSE_OVERSIGHT_014450 →

No Subject

HOUSE_OVERSIGHT_014460 - HOUSE_OVERSIGHT_014497

Nov 30, 2016Source: House Oversight

1 mention

vels. The fundamental bull case for Health rests on the strong pipeline of new products for the big cap pharma universe. Our sector analysts forecast EU Pharma to deliver a 2018-21E EPS CAGR of 11%, up from mid-single digit levels in recent years. Historically that would justify a PE re-rating and a multiple

Page: HOUSE_OVERSIGHT_014493 →

Connected Entities(50 of 329)

the Investment Industry Regulatory Organization of Canada